Abstract
Background: Cancers are in to accounted as chronic diseases that in many countries for recent decades have high rates of mortality. One of the most common cancers is breast cancer which is the second leading cause of cancer death in women after lung cancer. This study was performed to examine the 2-year and 5-year survival rate in pa- tients with metastatic breast cancer referring to Ahvaz Golestan Hospital Radiotherapy and oncology Department for the period of 2001-2007.
Materials and methods: This study was a retrospective investigation and the studied population was the patients who had been hospitalized with breast cancer in Ahvaz Golestan Hospital Radiotherapy and oncology Department. The duration of patients’ survival rate was evaluated by obtaining the data from the archives, records and tele- phone calls.
Results: In this study, a total number of 352 patients were studied for breast cancer. The most patients were in the age range of 40-49 years with the prevalence percentage of 38.6. The less than 2 year survival rate was 47%, 2-year survival rate of 41.5% and 5-year survival rate of 11.5%, respectively. The frequency percentage of bone metastasis only was 40.3% however; the 59.7% was recorded for visceral metastasis.
Conclusion: Given the study results the survival rate of patients with over time was fewer so that, with 2-fold time, the survival rate was decreased to about one third to one quarter. In addition, the incidence of bone metastasis was associated with a better prognosis.
Materials and methods: This study was a retrospective investigation and the studied population was the patients who had been hospitalized with breast cancer in Ahvaz Golestan Hospital Radiotherapy and oncology Department. The duration of patients’ survival rate was evaluated by obtaining the data from the archives, records and tele- phone calls.
Results: In this study, a total number of 352 patients were studied for breast cancer. The most patients were in the age range of 40-49 years with the prevalence percentage of 38.6. The less than 2 year survival rate was 47%, 2-year survival rate of 41.5% and 5-year survival rate of 11.5%, respectively. The frequency percentage of bone metastasis only was 40.3% however; the 59.7% was recorded for visceral metastasis.
Conclusion: Given the study results the survival rate of patients with over time was fewer so that, with 2-fold time, the survival rate was decreased to about one third to one quarter. In addition, the incidence of bone metastasis was associated with a better prognosis.
Keywords
Copyright
© 2015, Jundishapur Journal of Oncology. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.